Heatwurx (PCSA)
(Real Time Quote from BATS)
$0.24 USD
+0.01 (5.50%)
Updated Aug 7, 2025 12:44 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PCSA 0.24 +0.01(5.50%)
Will PCSA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PCSA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PCSA
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury ...
Processa secures strategic investment, evaluates crypto strategy
Processa terminates license agreement for PCS3117
PCSA: HC Wainwright & Co. Adjusts Price Target While Maintaining Buy Rating | PCSA Stock News
Processa Pharmaceuticals price target lowered by $4 at H.C. Wainwright, here's why